Swiss National Bank raised its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 12.2% during the 4th quarter, ...

Cibc World Markets Corp purchased a new stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) in the 4th quarter, ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...

For greater potential upside, consider earlier-stage smid-cap biotech names. Small- and midcap biotech stocks are riskier, but have been hardest hit in the sector's decline. "Smid-cap biotech looks ...

In today’s heightened enforcement environment, compliance auditing isn’t just a best practice—it’s a necessity. Federal and ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Researchers developed olfactory tests -- in which participants sniff odor labels that have been placed on a card -- to assess people's ability to discriminate, identify and remember odors. They found ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Researchers from Mass General Brigham developed olfactory tests—in which participants sniff odor labels that have been placed on a card—to assess people’s ability to discriminate, identify and ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.